Skip to main content
Erschienen in: Current Oncology Reports 7/2016

01.07.2016 | Palliative Medicine (A Jatoi, Section Editor)

“The Talk:” Discussing Hospice Care

verfasst von: Christine D. Hudak, Charles von Gunten

Erschienen in: Current Oncology Reports | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Referral of advanced cancer patients for hospice care is of growing importance for oncologists. Hospice care is high quality and high value care that can benefit the patient and family’s experience of living and dying with terminal cancer. We are challenged to become a part of the shift from hospice meaning “giving up” to hospice meaning “giving more, but differently.” The purpose of this report is to frame a communication approach that any oncologist can incorporate into his or her practice that will facilitate the timely referral of appropriate patients for hospice care. Combining the strengths of oncology, palliative, and hospice providers in a complementary fashion allows us to serve patients and their families in the most meaningful way.
Literatur
1.
Zurück zum Zitat Teno JM et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291(1):88–93.CrossRefPubMed Teno JM et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291(1):88–93.CrossRefPubMed
2.
Zurück zum Zitat Kelley AS et al. Hospice enrollment saves money for medicare and improves care quality across a number of different lengths of stay. Health Aff. 2013;32(3):552–61.CrossRef Kelley AS et al. Hospice enrollment saves money for medicare and improves care quality across a number of different lengths of stay. Health Aff. 2013;32(3):552–61.CrossRef
4.••
Zurück zum Zitat Jang RW et al. Simple prognostic model for patients with advanced cancer based on performance status. J Oncol Pract. 2014;10(5):e335–41. This study of advanced cancer patients correlated ECOG performance score with median survival in days of life. ECOG 0–293 days, ECOG 1–197 days, ECOG 2–104 days, ECOG 3–55 days, and ECOG 4–25 days. These data support that hospice referral would be appropriate for those with an ECOG score of 2 or higher.CrossRefPubMed Jang RW et al. Simple prognostic model for patients with advanced cancer based on performance status. J Oncol Pract. 2014;10(5):e335–41. This study of advanced cancer patients correlated ECOG performance score with median survival in days of life. ECOG 0–293 days, ECOG 1–197 days, ECOG 2–104 days, ECOG 3–55 days, and ECOG 4–25 days. These data support that hospice referral would be appropriate for those with an ECOG score of 2 or higher.CrossRefPubMed
5.
Zurück zum Zitat Schnipper LE et al. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol. 2012;30(14):1715–24.CrossRefPubMed Schnipper LE et al. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol. 2012;30(14):1715–24.CrossRefPubMed
6.•
Zurück zum Zitat Prigerson HG et al. Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol. 2015;1(6):778–84. This study found that patients with advanced cancer and a good performance status that elected to have chemotherapy experienced a worse quality in their last week of life.CrossRefPubMed Prigerson HG et al. Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol. 2015;1(6):778–84. This study found that patients with advanced cancer and a good performance status that elected to have chemotherapy experienced a worse quality in their last week of life.CrossRefPubMed
7.••
Zurück zum Zitat Temel JS et al. Early palliative care for patients with metastatic non-small-cell lung cancer. NEJM. 2010;363(8):733–42. Landmark article demonstrating that patients with metastatic non-small cell lung cancer who had palliative care alongside with routine oncology care had improved quality of life and less depression symptoms. Though the patients who were in the palliative care group received less aggressive end of life care, median survival improved by 2.7 months.CrossRefPubMed Temel JS et al. Early palliative care for patients with metastatic non-small-cell lung cancer. NEJM. 2010;363(8):733–42. Landmark article demonstrating that patients with metastatic non-small cell lung cancer who had palliative care alongside with routine oncology care had improved quality of life and less depression symptoms. Though the patients who were in the palliative care group received less aggressive end of life care, median survival improved by 2.7 months.CrossRefPubMed
8.••
Zurück zum Zitat Smtih TJ et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012;30:880–7. Review of available studies concluded that palliative care would benefit patients significantly if offered earlier in the course of advanced cancer.CrossRef Smtih TJ et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012;30:880–7. Review of available studies concluded that palliative care would benefit patients significantly if offered earlier in the course of advanced cancer.CrossRef
9.
Zurück zum Zitat NHPCO. Facts and figures: hospice care in America. Alexandria: National Hospice and Palliative Care Organization; 2014. NHPCO. Facts and figures: hospice care in America. Alexandria: National Hospice and Palliative Care Organization; 2014.
10.
Zurück zum Zitat Xu JQ et al. Deaths: final data for 2013. Natl Vital Stat Rep. 2016;64(2):1–119.PubMed Xu JQ et al. Deaths: final data for 2013. Natl Vital Stat Rep. 2016;64(2):1–119.PubMed
11.
Zurück zum Zitat NHPCO. Facts and figures: hospice care in America. National Hospice and Palliative Care Organization: Alexandria; 2015. NHPCO. Facts and figures: hospice care in America. National Hospice and Palliative Care Organization: Alexandria; 2015.
12.•
Zurück zum Zitat IOM (Institute of Medicine). Dying in America: improving quality and honoring individual preferences near the end of life. Washington, DC: The National Academies Press; 2015. Comprehensive evaluation of the current state of end of life care in America with recommendations to improve quality in the areas of “Delivery of person-centered, family-oriented care, Clinician-patient communication and advanced care planning, Professional education and development, Policies and payment systems and Public education and engagement”. IOM (Institute of Medicine). Dying in America: improving quality and honoring individual preferences near the end of life. Washington, DC: The National Academies Press; 2015. Comprehensive evaluation of the current state of end of life care in America with recommendations to improve quality in the areas of “Delivery of person-centered, family-oriented care, Clinician-patient communication and advanced care planning, Professional education and development, Policies and payment systems and Public education and engagement”.
14.
Zurück zum Zitat von Gunten CF. Discussing hospice care. J Clin Oncol. 2002;20(5):1419–24. von Gunten CF. Discussing hospice care. J Clin Oncol. 2002;20(5):1419–24.
Metadaten
Titel
“The Talk:” Discussing Hospice Care
verfasst von
Christine D. Hudak
Charles von Gunten
Publikationsdatum
01.07.2016
Verlag
Springer US
Erschienen in
Current Oncology Reports / Ausgabe 7/2016
Print ISSN: 1523-3790
Elektronische ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-016-0527-8

Weitere Artikel der Ausgabe 7/2016

Current Oncology Reports 7/2016 Zur Ausgabe

Integrative Care (C Lammersfeld, Section Editor)

The Use of Medical Marijuana in Cancer

Integrative Care (C Lammersfeld, Section Editor)

The Gut Microbiome and Obesity

Translational Oncology (L Vecchione, Section Editor)

Personalised Treatment in Gastric Cancer: Myth or Reality?

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.